Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRD205 in chronic postoperative neuralgia
NCT07123402Phase 2Enrolling by invitation
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- Apr 2025
- Primary completion
- Apr 2026
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TRD205 in Neuralgia, sponsored by Beijing Tide Pharmaceutical Co., Ltd.. Started Apr 2025; status: enrolling by invitation.
02
Drugs
TRD205
03
Conditions
Neuralgia
Beyond the preview
Go deeper on NCT07123402.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07123402.